AVID BIOSERVICES INC's ticker is CDMO and the CUSIP is 05368M106. A total of 167 filers reported holding AVID BIOSERVICES INC in Q1 2024. The put-call ratio across all filers is 2.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $839,577 | +3.1% | 125,310 | 0.0% | 0.00% | 0.0% |
| Q4 2023 | $814,516 | +8.3% | 125,310 | +57.3% | 0.00% | 0.0% |
| Q3 2023 | $752,057 | -45.3% | 79,667 | -19.0% | 0.00% | 0.0% |
| Q2 2023 | $1,374,466 | -1.8% | 98,387 | +31.9% | 0.00% | 0.0% |
| Q1 2023 | $1,399,758 | +39.2% | 74,614 | +2.2% | 0.00% | 0.0% |
| Q4 2022 | $1,005,637 | -25.3% | 73,031 | +3.7% | 0.00% | -50.0% |
| Q3 2022 | $1,347,000 | +35.4% | 70,426 | +8.0% | 0.00% | +100.0% |
| Q2 2022 | $995,000 | -45.1% | 65,222 | -26.7% | 0.00% | -50.0% |
| Q1 2022 | $1,812,000 | -10.8% | 88,929 | +27.8% | 0.00% | +100.0% |
| Q4 2021 | $2,031,000 | +36.7% | 69,598 | +1.0% | 0.00% | 0.0% |
| Q3 2021 | $1,486,000 | +50.1% | 68,905 | +78.6% | 0.00% | 0.0% |
| Q2 2021 | $990,000 | +376.0% | 38,579 | +114.0% | 0.00% | – |
| Q4 2020 | $208,000 | +220.0% | 18,024 | +44.8% | 0.00% | – |
| Q3 2019 | $65,000 | -3.0% | 12,444 | +3.5% | 0.00% | – |
| Q2 2019 | $67,000 | +34.0% | 12,025 | +1.7% | 0.00% | – |
| Q1 2019 | $50,000 | -7.4% | 11,822 | -13.8% | 0.00% | – |
| Q2 2018 | $54,000 | – | 13,710 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ISZO CAPITAL MANAGEMENT LP | 2,346,961 | $50,624,000 | 22.33% |
| AltraVue Capital, LLC | 2,464,316 | $53,155,000 | 7.86% |
| Sargent Investment Group, LLC | 812,113 | $17,517,000 | 4.26% |
| AWM Investment Company, Inc. | 1,233,000 | $26,596,000 | 2.61% |
| Ranger Investment Management | 2,211,560 | $47,703,000 | 2.54% |
| Parkman Healthcare Partners LLC | 450,000 | $9,707,000 | 2.46% |
| Legato Capital Management LLC | 305,114 | $6,581,000 | 1.25% |
| SNYDER CAPITAL MANAGEMENT L P | 1,780,935 | $38,415,000 | 1.02% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 730,750 | $15,762,000 | 0.90% |
| Pier Capital, LLC | 361,287 | $7,793,000 | 0.81% |